Search results
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 20 hours agoKeytruda (pembrolizumab) is Merck & Co Inc’s (NYSE:MRK) top selling cancer drug. The abstract...
Justice Department Opts Not to Charge Merck KGaA Subsidiary Over Export Controls Scheme
The Wall Street Journal· 3 days agoTwo men, including a former employee of the German company’s subsidiary, MilliporeSigma, pleaded...
Billionaire Ken Griffin Is Buying These Dividend Stocks Hand Over Fist. Should You? | The Motley...
The Motley Fool· 1 day agoThe billionaire hedge fund manager doesn't need dividend income. But he'll get more of it after his...
Dow Jones Rises Ahead Of Inflation Report; AI Stock Workday Plunges On Earnings
Investor's Business Daily· 1 day agoToday: Best Stocks To Watch Monday.com, Netflix and Nvidia chipmaker Taiwan Semiconductor...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: American Express,...
Zacks· 5 days agoReport) , Walmart Inc. (WMT Quick QuoteWMT - Free Report) , Amazon.com Inc. (AMZN Quick QuoteAMZN - Free Report) , The Goldman Sachs Group Inc. (GS Quick QuoteGS - Free Report) and ...
Why This Top 4% Biotech Just Catapulted To A Record High
Investor's Business Daily· 19 hours agoThe Netherlands-based biotech paired its drug, petosemtamab, with Merck's (MRK) cancer blockbuster,...
Why Top 4% Biotech Stock, Merus, Just Catapulted To A Record High
Investor's Business Daily· 19 hours agoMerus stock catapulted to a record high Friday after its experimental regimen for head-and-neck...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
Motley Fool via Yahoo Finance· 1 day ago(For example, it helps drug companies manage their clinical trials.) Its myriad customers include...
‘It made my penis change shape’: Inside the hair loss drug controversy
The Telegraph via Yahoo News· 3 days agoA few years ago, James* was at the pub with colleagues when a female co-worker walked behind him to...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe Phase II study is evaluating petosemtamab in combination with Merck & Co’s PD-1 inhibitor...